Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Harmonic Inc
HLIT
$1.28B
| $14M | ﹤0.01% |
1,640,677
+5,174
| +0.3% | +$39.6K |
|
2227
Scansource
SCSC
$1.16B
| $14M | ﹤0.01% |
496,222
+11,046
| +2% | +$329K |
|
|
TRTX
2228
TPG RE Finance Trust
TRTX
$619M
| $13.9M | ﹤0.01% |
1,037,169
+70,214
| +7% | +$900K |
|
2229
Latham Group
SWIM
$662M
| $13.9M | ﹤0.01% |
+435,933
| New | +$12.7M |
|
2230
Pulmonx
LUNG
$89.5M
| $13.9M | ﹤0.01% |
315,178
+109,152
| +53% | +$4.75M |
|
2231
Amphastar Pharmaceuticals
AMPH
$892M
| $13.9M | ﹤0.01% |
689,084
+28,671
| +4% | +$540K |
|
2232
BlackBerry
BB
$4.99B
| $13.9M | ﹤0.01% |
1,145,822
+74,180
| +7% | +$777K |
|
2233
Univest Financial
UVSP
$1.23B
| $13.9M | ﹤0.01% |
525,965
+7,423
| +1% | +$209K |
|
2234
DigitalOcean
DOCN
$14.9B
| $13.8M | ﹤0.01% |
+248,696
| New | +$10.7M |
|
2235
Weibo
WB
$2.01B
| $13.8M | ﹤0.01% |
263,935
+31,317
| +13% | +$1.55M |
|
2236
Personalis
PSNL
$1.41B
| $13.8M | ﹤0.01% |
543,950
+83,523
| +18% | +$1.91M |
|
2237
Wabash National
WNC
$508M
| $13.7M | ﹤0.01% |
857,170
-19,875
| -2% | -$341K |
|
2238
AdvanSix
ASIX
$542M
| $13.7M | ﹤0.01% |
458,059
+9,325
| +2% | +$280K |
|
2239
Alignment Healthcare
ALHC
$3.02B
| $13.7M | ﹤0.01% |
584,519
+453,019
| +345% | +$11M |
|
|
PAYA
2240
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $13.7M | ﹤0.01% |
1,239,274
+695,456
| +128% | +$7.41M |
|
|
HONE
2241
DELISTED
HarborOne Bancorp
HONE
| $13.7M | ﹤0.01% |
952,171
-15,397
| -2% | -$222K |
|
|
EPZM
2242
DELISTED
Epizyme, Inc
EPZM
| $13.6M | ﹤0.01% |
1,641,492
+50,432
| +3% | +$425K |
|
2243
Hydrofarm Holdings
HYFM
$10.2M
| $13.6M | ﹤0.01% |
23,054
+6,379
| +38% | +$3.75M |
|
|
EFC
2244
Ellington Financial
EFC
$1.67B
| $13.6M | ﹤0.01% |
710,413
+5,921
| +0.8% | +$109K |
|
2245
WisdomTree
WT
$3.21B
| $13.6M | ﹤0.01% |
2,191,862
+51,876
| +2% | +$342K |
|
2246
ProPetro Holding
PUMP
$1.37B
| $13.6M | ﹤0.01% |
1,482,602
+106,210
| +8% | +$1.1M |
|
|
LOGC
2247
DELISTED
ContextLogic
LOGC
| $13.6M | ﹤0.01% |
34,348
+9,739
| +40% | +$3.45M |
|
2248
Theravance Biopharma
TBPH
$874M
| $13.5M | ﹤0.01% |
932,268
+93,905
| +11% | +$1.76M |
|
|
NEX
2249
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $13.5M | ﹤0.01% |
2,839,726
+208,646
| +8% | +$916K |
|
2250
Clover Health Investments
CLOV
$2.28B
| $13.5M | ﹤0.01% |
1,013,429
+44,832
| +5% | +$440K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.